• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pancreatic Cancer Drug Pathway Analyzer 2014 Product Image

Pancreatic Cancer Drug Pathway Analyzer 2014

  • ID: 2673680
  • July 2014
  • Region: Global
  • Bioseeker

Extra value: One year of free online updates included with this product

There are today at least 294 targeted molecular therapies known to affect more than 246 specific intracellular signaling pathways for the treatment of pancreatic cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 255 drug targets that are included in this drug-pathway analyzing tool. No less than 249 of these have been recorded with mutations and 45 drug targets have mutations which have been causally implicated in cancer.

Pathway Coverage
- BioCarta# 242 Pathways
- KEGG# 196 Pathways
- NCI-Nature# 246 Pathways
- NetPath# 32 Pathways

Pipeline Coverage
Marketed# 14
Pre-registration# 1
Phase III# 24
Phase II# 119
Phase I# 85
Preclinical# 74
Suspended# 1
Ceased# 114

The continuous identification of drug targets and pathways that are altered in cancer is not only crucial for our understanding of cancer biology, but also to search for new targets for early diagnosis and improved treatment designs. Consequently, it has never before been as important to rapidly translate systems biology of disease READ MORE >

Delivery Format: Desktop App plus Online Access to Updates (One Year)

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos